# Understanding the Immune Response to Meningitis Vaccines

> **NCT00901940** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 150 (actual)

## Conditions studied

- Meningitis
- Septicemia

## Interventions

- **BIOLOGICAL:** Meningococcal (Groups A, C, Y and W-135) Conjugate
- **BIOLOGICAL:** Meningococcal polysaccharide A, C, Y and W135 and Menveo

## Key facts

- **NCT ID:** NCT00901940
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901940, "Understanding the Immune Response to Meningitis Vaccines". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00901940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*